FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 142 filers reported holding FLEXION THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,148,000 | -85.8% | 55,458 | -90.6% | 0.00% | -100.0% |
| Q3 2019 | $8,074,000 | +9.3% | 589,105 | -1.9% | 0.00% | 0.0% |
| Q2 2019 | $7,387,000 | -13.3% | 600,603 | -12.0% | 0.00% | 0.0% |
| Q1 2019 | $8,516,000 | -15.9% | 682,333 | -23.7% | 0.00% | -33.3% |
| Q4 2018 | $10,127,000 | -3.8% | 894,560 | +59.1% | 0.00% | +50.0% |
| Q3 2018 | $10,523,000 | -20.9% | 562,413 | +9.3% | 0.00% | -33.3% |
| Q2 2018 | $13,299,000 | +41.7% | 514,475 | +22.8% | 0.00% | +50.0% |
| Q1 2018 | $9,385,000 | -12.2% | 418,797 | +0.7% | 0.00% | 0.0% |
| Q4 2017 | $10,688,000 | -32.9% | 416,067 | -36.8% | 0.00% | -50.0% |
| Q3 2017 | $15,924,000 | +21.8% | 658,545 | +1.9% | 0.00% | +33.3% |
| Q2 2017 | $13,070,000 | -28.4% | 646,405 | -4.7% | 0.00% | -25.0% |
| Q1 2017 | $18,251,000 | +41.5% | 678,226 | 0.0% | 0.00% | +33.3% |
| Q4 2016 | $12,900,000 | +3.5% | 678,226 | +6.3% | 0.00% | 0.0% |
| Q3 2016 | $12,463,000 | +28.4% | 637,806 | -1.6% | 0.00% | 0.0% |
| Q2 2016 | $9,703,000 | +88.8% | 648,396 | +16.1% | 0.00% | +200.0% |
| Q1 2016 | $5,139,000 | -79.3% | 558,603 | -56.7% | 0.00% | -85.7% |
| Q4 2015 | $24,882,000 | +33.0% | 1,291,245 | +2.6% | 0.01% | +40.0% |
| Q3 2015 | $18,704,000 | +285.9% | 1,258,714 | +468.5% | 0.01% | +400.0% |
| Q2 2015 | $4,847,000 | – | 221,424 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Investment Advisors, Ltd. | 23 | $0 | 0.00% |